Joseph Saveri founded the firm in 2012. It has rapidly amassed a successful track record by leading several significant groundbreaking and precedent-setting cases. The firm has served as lead and co-counsel on various cases involving: price-fixing; illegal pharmaceutical 'pay-for-delay' agreements including the drugs Cipro, Lidoderm, Restasis, and Opana ER; 'no-poach' agreements regarding hiring and recruiting; and antitrust cases involving athletes and sports leagues. It is regularly appointed to leadership positions in antitrust and other complex cases throughout the United States.
The firm represents individuals and businesses in complex commercial disputes. It specializes in plaintiffs’ antitrust ligation and is widely regarded as one of the nation’s leading firms in this field. The firm’s attorneys have generated $4 billion in settlements and successful resolutions for its clients. The firm has received numerous accolades, including being ranked 2013-present by Best Lawyers/U.S. News and World Report’s Best Law Firms publication and honored by the American Antitrust Institute for 'Outstanding Antitrust Litigation Achievement in Private Law Practice' (it has also been a finalist for this award). It is one of 20 firms recognized for excellence in The Legal 500’s 'United States Antitrust Civil Litigation/Class Actions: Plaintiff' category. And, it has been awarded by the California Daily Journal as one of the 'Top Boutiques' in California in 2016 and 2018.
The firm continues to rapidly and thoughtfully expand. It has done so through its successful representation of entrepreneurs and sophisticated businesses, as well as its strong record of handling novel and challenging legal matters. The firm’s array of active cases and investigations has grown fivefold since 2012, with over 50% expansion taking place since 2017. Consequently, the firm has quadrupled its original attorney staff, growing over 70% since 2017. Throughout this growth, the firm has showcased its strong commitment to diversity, with the number of women and minority attorneys growing sixfold since 2017.
The firm’s attorneys have received numerous individual awards and have emerged as thought leaders, frequently speaking, lecturing, and writing on antitrust, civil procedure, and other matters. Their collective experience, success, and professional recognition rival that of any firm in their industry, regardless of tenure or size. They possess deep experience in both civil and criminal trial practice, federal district court and appellate court clerkships, and plaintiff-side and defense-side litigation, as well as in-house counsel experience and multilingual ability.
Complex Business Disputes
Qui Tam & Whistleblower
• In re Cipro Cases I and II: Co-Lead Counsel successfully representing a class of California consumers and insurers who brought antitrust claims against Bayer Corporation, Barr Laboratories, and other generic drug manufacturers, alleging that the companies paid drug manufacturers to delay the release of a Cipro alternative. In May 2015, The California Supreme Court ruled in Plaintiffs’ favor: a ground-breaking holding that these type of 'pay-for-delay' arrangements were subject to antitrust scrutiny under California law and adopting a 'structured' rule of reason that curtailed available defenses. The case settled in 2017 for $399 million: a record for this type of case
• In re Capacitors Price-Fixing Antitrust Litigation: Sole Lead Counsel currently in a class action alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. Capacitors are devices placed in electric circuits that temporarily store electrical charge, and nearly every electronic device manufactured today contains them. The firm seeks damages relief for a Direct Purchasers Plaintiff Class for the unlawful overcharge on capacitors resulting from the Defendants’ alleged collusion. Class is certified and trial is in progress (pending the coronavirus pandemic). To date, Settlements reached with 13 of the original Defendants to the action total $343.5 million
• In re High-Tech Employees Antitrust Litigation: Served as Co-Lead Class Counsel for a class of over 60,000 employees of leading technology companies such as Google and Apple against their employers for their alleged agreements to restrict recruiting to suppress wages. Three Defendants agreed to settlements, now finalized, totaling $20 million. Following the Court’s denial of their motions for summary judgment, the remaining Defendants agreed to a settlement totaling $415 million, which has also received final approval
• In re Titanium Dioxide Antitrust Litigation: Served as Co-Lead Counsel to a class of direct purchasers of titanium dioxide who alleged that several primary suppliers engaged in an unlawful conspiracy to raise, maintain, or stabilize prices for titanium dioxide in the United States. The case produced a $163.5 million settlement.